Rampart Bioscience: Funding, Investors & Team (Oct 2026)
Rampart Bioscience specializes in the creation of gene-based medications that offer prolonged relief for various illnesses. Additionally, the company provides exclusive development and delivery platforms that enhance the effectiveness of these treatments in a reversible, non-viral manner. Moreover, Rampart Bioscience supports patients with genetically caused diseases by leveraging expertise from multiple scientific fields, such as gene delivery, protein sciences, and clinical research.
Rampart Bioscience has raised $85.0M across 1 funding round on record, the most recent a Series A of $85.0M announced in Oct 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rampart Bioscience Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Rampart Bioscience Funding Rounds
Rampart Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
Rampart Bioscience Funding Compared to Other Biotechnology Startups
Rampart Bioscience's latest round of $85.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rampart Bioscience in Biotechnology and La Jolla
Companies Similar to Rampart Bioscience
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Rampart Bioscience Funding FAQs
What does Rampart Bioscience do?
Rampart Bioscience specializes in the creation of gene-based medications that offer prolonged relief for various illnesses. Additionally, the company provides exclusive development and delivery platforms that enhance the effectiveness of these treatments in a reversible, non-viral manner. Moreover, Rampart Bioscience supports patients with genetically caused diseases by leveraging expertise from multiple scientific fields, such as gene delivery, protein sciences, and clinical research.
How much funding has Rampart Bioscience raised?
Rampart Bioscience has raised $85.0M across 1 round on record. The most recent is a Series A of $85.0M announced in Oct 2023.
When did Rampart Bioscience last raise funding?
Rampart Bioscience's most recent funding round on record is a Series A of $85.0M, announced in Oct 2023.
Who is the CEO of Rampart Bioscience?
Louis Breton is listed as CEO at Rampart Bioscience.
Where is Rampart Bioscience headquartered?
Rampart Bioscience is based in La Jolla, California, United States.
How many employees does Rampart Bioscience have?
Rampart Bioscience is in the 11-50 employee band.
How does Rampart Bioscience's funding compare to other Biotechnology startups?
Rampart Bioscience's latest round of $85.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rampart Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rampart Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.